Accordingly, elevated levels of protective PUFAs might contribute to improved mitochondrial function (i.e., increased β-HAD activity and PPARα activation) to attenuate development of metabolic disease in PQQ-supplemented offspring. Here, PPARA is linked to metabolic disease.